A total of 127 neuroblastoma patients with known clinicopathological characteristics and survival data were selected from the TARGET database and categorized into either bub1 high expression (n=63) or bub1 low expression (n=64) groups, using the median value of bub1 expression in all patients as the cutoff (Table 2). The gene discussed is BUB1; the disease is neuroblastoma.